[RGLS] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
09-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- 13.59%
YoY- 35.92%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 6,778 18 18 18 18 18 18 5133.46%
PBT -3,260 -8,502 -10,273 -13,847 -16,024 -14,506 -15,835 -65.16%
Tax 56 61 201 118 1 -58 -7 -
NP -3,260 -8,563 -10,273 -13,847 -16,025 -14,448 -15,828 -65.15%
Tax Rate - - - - - - - -
Total Cost 10,038 8,581 10,291 13,865 16,043 14,466 15,846 -26.26%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin -48.10 -47,572.22 -57,072.22 -76,927.78 -89,027.78 -80,266.67 -87,933.33 -99.33%
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS -3.14 -9.75 -11.80 -15.93 -18.49 -16.68 -21.09 -71.94%
EPS Diluted -3.14 -9.75 -11.80 -15.93 -18.49 -16.68 -21.09 -71.94%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.